[go: up one dir, main page]

NO972278L - Fluorerte vitamin D3-analoger - Google Patents

Fluorerte vitamin D3-analoger

Info

Publication number
NO972278L
NO972278L NO972278A NO972278A NO972278L NO 972278 L NO972278 L NO 972278L NO 972278 A NO972278 A NO 972278A NO 972278 A NO972278 A NO 972278A NO 972278 L NO972278 L NO 972278L
Authority
NO
Norway
Prior art keywords
double bond
hydrogen
bond
alkyl
independently
Prior art date
Application number
NO972278A
Other languages
English (en)
Norwegian (no)
Other versions
NO972278D0 (no
Inventor
Percy Sarwood Manchand
Jr John Joseph Nestor
Milan Radoje Uskokovic
Brian Henry Vickery
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO972278D0 publication Critical patent/NO972278D0/no
Publication of NO972278L publication Critical patent/NO972278L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO972278A 1996-05-23 1997-05-20 Fluorerte vitamin D3-analoger NO972278L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1821996P 1996-05-23 1996-05-23
US3990197P 1997-03-19 1997-03-19

Publications (2)

Publication Number Publication Date
NO972278D0 NO972278D0 (no) 1997-05-20
NO972278L true NO972278L (no) 1997-11-24

Family

ID=26690870

Family Applications (1)

Application Number Title Priority Date Filing Date
NO972278A NO972278L (no) 1996-05-23 1997-05-20 Fluorerte vitamin D3-analoger

Country Status (26)

Country Link
EP (1) EP0808832B1 (pt)
JP (1) JP2859248B2 (pt)
KR (1) KR100253961B1 (pt)
CN (1) CN100402497C (pt)
AR (1) AR007776A1 (pt)
AT (1) ATE238278T1 (pt)
AU (1) AU733970B2 (pt)
BR (1) BR9703385A (pt)
CA (1) CA2205315C (pt)
CO (1) CO4940503A1 (pt)
CZ (1) CZ157797A3 (pt)
DE (1) DE69721123T2 (pt)
DK (1) DK0808832T3 (pt)
ES (1) ES2195049T3 (pt)
HR (1) HRP970272A2 (pt)
HU (1) HUP9700928A3 (pt)
IL (1) IL120844A0 (pt)
MA (1) MA24250A1 (pt)
NO (1) NO972278L (pt)
NZ (1) NZ314840A (pt)
PE (1) PE66798A1 (pt)
PL (1) PL320130A1 (pt)
PT (1) PT808832E (pt)
SG (1) SG70010A1 (pt)
TR (1) TR199700416A2 (pt)
YU (1) YU20097A (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6008209A (en) * 1997-04-28 1999-12-28 Hoffmann-La Roche Inc. Method of using vitamin D3 analogs with bis C-20 side chains
DE19935771A1 (de) 1999-07-23 2001-02-01 Schering Ag Neue Vitamin D-Derivate mit cyclischen Substrukturen in den Seitenketten, Verfahren und Zwischenprodukte zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln
WO2002013832A1 (fr) * 2000-08-17 2002-02-21 Chugai Seiyaku Kabushiki Kaisha Agent therapeutique destine au traitement de l'osteoporose
CA2459789A1 (en) * 2001-09-21 2003-04-03 F. Hoffmann-La Roche Ag 3-desoxy-vitamin d3 analog esters
PT103177A (pt) 2003-09-24 2005-03-31 Bioxell Spa 1-alfa-fluoro-25-hidroxi-16,23e-dieno-26,27-bis-homo-20-epi-colecalciferol, seus sais ou esteres e sua utilizacao no fabrico de medicamentos
WO2006036813A2 (en) * 2004-09-24 2006-04-06 Bioxell S.P.A. 20-cycloalkyl,26,27-alkyl/haloalkyl vitamin d3 compounds and methods of use thereof
CA2601914A1 (en) * 2005-03-23 2006-09-28 Bioxell S.P.A. 20-alkyl, gemini vitamin d3 compounds and methods of use thereof
CN104829510B (zh) 2010-10-25 2016-05-04 帝人制药株式会社 23-炔-维生素d3衍生物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4141746A1 (de) * 1991-12-13 1993-06-17 Schering Ag 20-methyl-substituierte vitamin d-derivate
DE4220757A1 (de) * 1992-06-24 1994-01-05 Schering Ag Derivate in der Vitamin D-Reihe mit Modifikationen in der 20-Position, Verfahren zu ihrer Herstellung, Zwischenprodukte für dieses Verfahren, diese Derivate enthaltende pharmazeutische Präparate sowie deren Verwendung zur Herstellung von Arzneimitteln
US5428029A (en) * 1993-11-24 1995-06-27 Hoffmann-La Roche Inc. Vitamin D3 fluorinated analogs
US5384314B1 (en) * 1994-03-11 1997-08-05 Hoffmann La Roche 1alpha-fluoro-25-hydroxy-16-ene-23-yne-cholecalciferol
AU7295696A (en) * 1995-10-27 1997-05-22 F. Hoffmann-La Roche Ag Pharmaceutical composition for treating osteoporosis

Also Published As

Publication number Publication date
EP0808832B1 (en) 2003-04-23
HRP970272A2 (en) 1998-04-30
JP2859248B2 (ja) 1999-02-17
KR100253961B1 (ko) 2000-04-15
SG70010A1 (en) 2000-01-25
MX9703775A (es) 1998-06-30
CN100402497C (zh) 2008-07-16
PE66798A1 (es) 1998-10-22
CO4940503A1 (es) 2000-07-24
TR199700416A2 (xx) 1997-12-21
EP0808832A2 (en) 1997-11-26
CZ157797A3 (en) 1997-12-17
NZ314840A (en) 1998-11-25
AR007776A1 (es) 1999-11-24
ES2195049T3 (es) 2003-12-01
IL120844A0 (en) 1997-09-30
HUP9700928A3 (en) 1999-07-28
PL320130A1 (en) 1997-11-24
EP0808832A3 (en) 1999-02-03
HU9700928D0 (en) 1997-07-28
CN1172801A (zh) 1998-02-11
MA24250A1 (fr) 1998-04-01
ATE238278T1 (de) 2003-05-15
DE69721123D1 (de) 2003-05-28
DK0808832T3 (da) 2003-08-11
NO972278D0 (no) 1997-05-20
AU2357697A (en) 1997-11-27
PT808832E (pt) 2003-07-31
HUP9700928A2 (hu) 1998-01-28
JPH1045714A (ja) 1998-02-17
CA2205315A1 (en) 1997-11-23
DE69721123T2 (de) 2004-01-08
KR970074764A (ko) 1997-12-10
BR9703385A (pt) 1998-09-15
AU733970B2 (en) 2001-05-31
CA2205315C (en) 2006-10-24
YU20097A (sh) 1999-09-27

Similar Documents

Publication Publication Date Title
AU564842B2 (en) Pyranyl (or cyclohexyl) methane sulfamates and their use as anticonvulsants
HU9401950D0 (en) New aryl- and heteroaryl-ethylene derivatives and process for producing them
MY132867A (en) Acid-stable borates for photopolymerization
ATE133661T1 (de) Fluorierte kohlenwasserstoffderivate, ihre verwendung in kosmetischen zusammensetzungen, verfahren zu ihrer herstellung und sie enthaltende kosmetische zusammensetzungen
DK0707472T3 (da) Fremgangsmåde til regulering af størrelsen af liposomer
MY113419A (en) Mixtures of mono-and bis-resorclnyl-2-nydroxyphenyltriazine uv absorbers and their use as stabilizers for organic materials
NO972278L (no) Fluorerte vitamin D3-analoger
ID18576A (id) Senyawa antara untuk membuat turunan-turunan steroid yang digunakan dalam pengobatan hipertropi prostatik dan pembuatannya
GB2283016A (en) Scavenging of hydrogen sulphide
PT80817A (en) Process for the preparation of carbamates,thiocarbamates and dithiocarbamates and their substituted derivatives containing aromatic radicals
ES8601843A1 (es) Procedimiento para el tratamiento de textiles
ES2164700T3 (es) Procedimiento para preparar carbinoles de aril-piperidina.
AU1706495A (en) Stabilizer mixture made up of chromane derivatives, organic phosphites or phosphonites and amines
GR3019220T3 (en) Stable moulding or spinning compound containing cellulose.
EA199800468A1 (ru) 25-гидрокси-16-ен-26,27-бисгомохолекальциферолы
JPS5735506A (en) Bleaching cosmetic
NO940113L (no) Syntese av 2-fenyl-substituerte 1,3-propandioler
FI832007L (fi) En ny mikroorganismstam chromobacterium violaceum, medelst denna stam framstaellda farmaceutiskt aktiva foereningar, ett foerfarande foer framstaellning av foereningarna och anvaendning av dessa foereningar som laekemedel
AU683148B2 (en) Cyclohexane derivatives, process for their preparation, and the use of the compounds for the treatment of diseases
HU9502180D0 (en) Piperazine derivatives for producing alkil-trazodone derivatives and process for producing them
ATE195115T1 (de) Verfahren zur herstellung von 5,6-dihydroxy-2- amino-1,2,3,4-tetrahydronaphthalin-derivaten
FI925618A0 (fi) Etanoladdukter av 6-sulfonylsubstituerade 3-hydroxikromaner och deras anvaendning som inhalationsmedel vid sjukdomar
AU3093689A (en) Adhesive
SU1837613A1 (ru) Гидрофобизатор для обработки бетона
US4268669A (en) 9-Deoxy-9-methylene-5,6-didehydro-PGF1 amides